influenza
virus
iv
wide
spread
among
divers
host
lead
season
outbreak
annual
cost
million
human
live
signific
econom
highli
pathogen
avian
influenza
hpai
firstli
report
transmit
poultri
human
hong
ever
sinc
subtyp
continu
circul
domest
wild
bird
sporad
caus
human
infect
case
countri
document
world
health
organ
fatal
rate
among
case
confirm
china
http
wwwwhointinfluenzahumananimalinterfacehairiskassessmenten
exposur
sick
poultri
consid
major
risk
factor
howev
sever
episod
potenti
humantohuman
transmiss
rais
concern
strainmatch
vaccin
view
best
prevent
strategi
iv
wherea
develop
vaccin
encount
extra
obstacl
season
flu
one
hand
viru
lethal
chicken
embryo
thu
yield
eggdepend
inactiv
vaccin
larg
restrict
hand
oper
hpai
perform
biosafeti
level
facil
moreov
neutral
antibodybas
vaccin
usual
take
sever
day
onset
thu
novel
eggfre
avian
iv
vaccin
could
take
immedi
effect
could
appropri
supplementari
rna
interfer
rnai
conserv
sequencespecif
silenc
mechan
eukaryot
mediat
short
doublestrand
small
rna
sirna
mirna
includ
suppress
target
gene
express
posttranscript
mrna
cleavag
translat
especi
artifici
microrna
amirna
backbon
known
cellular
premirna
reduc
depend
host
factor
enhanc
safeti
thirdgener
gene
silenc
technolog
wide
util
treatment
infecti
describ
applic
amirna
control
complement
tradit
vaccin
studi
exploit
adenoviru
deliv
hemagglutininspecif
artifici
microrna
novel
antivir
agent
test
prophylaxi
efficaci
icr
mice
four
clade
includ
clade
clade
clade
clade
circul
china
ref
prove
influenzatarget
recombin
adenovirusdeliv
artifici
mirna
radamirna
could
combat
lethal
infect
amelior
sever
symptom
respect
lung
viral
yield
inflamm
surviv
hemagglutinin
gene
one
major
determin
pathogen
prove
ha
close
relat
system
infect
impair
immun
therefor
select
ha
gene
rnai
target
four
amirna
score
highest
accord
onlin
rnai
design
http
rnaidesignerinvitrogencomrnaiexpress
gener
describ
materi
method
includ
preamirna
sequenc
display
tabl
evalu
inhibitori
effect
amirna
construct
transfect
aforement
amirna
plasmid
separ
hek
cell
hour
influenza
challeng
transduc
cell
infect
moi
lyse
trizol
rna
isol
hour
later
negmirna
control
plasmidtr
cell
use
mock
control
flu
gene
express
level
set
depict
figur
amirna
treatment
significantli
lower
viral
product
compar
correspond
control
p
among
four
amirna
exhibit
strongest
inhibit
clade
mean
viral
load
clade
mean
viral
load
mean
suppress
clade
next
mean
viral
load
latter
one
less
effici
three
clade
clade
four
amirna
show
similar
effect
base
vitro
screen
result
chose
perform
experi
one
difficulti
rnai
clinic
applic
transduc
amirna
target
site
high
effici
minim
toxic
previou
data
prove
adenoviru
vector
one
ideal
candid
consid
tissu
tropism
insert
whole
amirna
express
cassett
region
rescu
recombin
adenoviru
term
rad
examin
whether
rad
could
suppress
growth
vitro
perform
hatarget
western
blot
vero
cell
plaqu
reduct
assay
canin
kidney
mdck
cell
figur
express
ha
significantli
reduc
rad
transduc
vero
cell
infect
either
clade
viru
inhibit
effici
exhibit
dosedepend
manner
figur
noteworthi
ha
express
clade
cell
nearli
abolish
presenc
viru
particl
vp
rad
furthermor
inhibit
influenza
plaqu
format
assess
mdck
cell
shown
figur
number
plaqu
significantli
lower
presenc
vp
rad
four
clade
challeng
compar
correspond
control
clade
p
clade
p
clade
p
clade
p
pretreat
vp
rad
slightli
decreas
averag
plaqu
format
four
strain
signific
differ
detect
compar
correspond
control
clade
p
clade
p
clade
p
clade
p
among
four
clade
rad
display
strongest
inhibitori
activ
clade
around
fivefold
mean
plaqu
count
vp
rad
vp
radempti
figur
suppress
clade
rang
twofold
threefold
figur
inhibit
effici
adenovirusexpress
amirna
total
correl
plasmid
screen
result
figur
assum
differ
cell
type
infect
dose
detect
sensit
might
lead
diverg
assess
effect
replic
inhibit
clinic
outcom
inocul
icr
mice
intranas
vp
rad
radempti
n
hour
prior
challeng
five
mice
group
euthan
lung
viral
rna
titrat
histolog
score
day
post
infect
dpi
clinic
symptom
rest
mice
monitor
daili
basi
day
figur
describ
protect
effici
clade
mean
lung
viral
copi
rad
inocul
mice
lower
comparison
radempti
group
p
figur
hematoxylin
eosin
stain
prove
lung
section
control
mice
display
sever
perivascular
interstiti
infiltr
mean
histolog
score
patholog
smallarea
perivascular
infiltr
observ
rad
group
mean
histolog
score
p
figur
c
furthermor
consist
reduc
viral
titer
less
pronounc
inflamm
respons
rad
protect
icr
mice
lethal
infect
clade
p
figur
surviv
mice
rad
group
lost
initi
weight
around
day
gradual
recov
figur
contrast
control
mice
suffer
constant
weight
loss
die
requir
euthanasia
day
thu
rad
confer
signific
protect
clade
challeng
test
whether
rad
could
provid
protect
clade
icr
mice
vaccin
challeng
depict
figur
rad
inocul
remark
decreas
fold
lung
viral
rna
copi
p
mean
histolog
score
p
four
rad
treat
mice
surviv
clade
infect
p
maxim
weight
loss
peak
day
figur
e
rademptytr
mice
show
similar
weight
chang
pattern
dpi
continu
lose
weight
till
death
term
clade
reduct
lung
viral
copi
also
signific
p
declin
less
obviou
two
clade
decreas
figur
averag
patholog
score
rad
radempti
group
p
respect
figur
c
ivspecif
amirna
rescu
icr
mice
lethal
challeng
clade
p
allevi
associ
symptom
figur
e
figur
show
protect
effici
toward
clade
although
rad
notabl
decreas
lung
viral
load
p
inflamm
p
treat
mice
succumb
subsequ
lethal
infect
therefor
prove
rad
could
confer
substanti
protect
clade
eas
symptom
caus
clade
control
hpai
human
infect
sever
challeng
sinc
centuri
viru
evolv
phylogenet
distinct
clade
subclad
among
clade
report
caus
human
china
clade
cocircul
poultri
threat
public
although
vaccin
costeffect
iv
intervent
strategi
product
vaccin
face
technic
obstacl
season
flu
vaccin
moreov
reappear
drugresist
strain
limit
use
current
avail
antivir
drug
underscor
urgent
demand
novel
fluspecif
end
develop
sequencebas
antivir
compound
help
rnai
rnai
exploit
promis
strategi
antivir
purpos
small
rna
target
genom
ebola
hepat
c
prove
effect
preclin
studi
recent
antisens
oligonucleotid
fomivirsen
approv
food
drug
administr
treat
howev
find
way
clinic
applic
small
rna
compound
expand
halflif
lower
toxic
reach
target
site
precis
previou
studi
demonstr
chimpanze
adenoviru
serotyp
suitabl
deliveri
vector
artifici
microrna
influenza
adenovirusdeliv
amirna
target
conserv
intern
gene
nucleoprotein
matrix
protect
icr
mice
complet
homolog
wherea
two
radamirna
confer
protect
one
clade
viru
therefor
sought
enhanc
effici
toward
silenc
flu
gene
studi
chose
hemagglutinin
gene
target
site
follow
reason
ha
main
flu
pathogen
determin
multibas
cleavag
site
highli
pathogen
ha
close
relat
system
ii
ha
differ
could
reduc
perforin
express
cell
might
contribut
impair
viru
clearanc
activ
subsequ
increas
proinflammatori
henc
design
four
amirna
base
ha
gene
distinct
clade
vitro
screen
one
amirna
incorpor
genom
extend
vivo
protect
experi
shown
figur
rad
remark
enhanc
mice
surviv
face
clade
challeng
effici
clade
clade
clade
virus
respect
figur
although
surviv
rate
significantli
differ
control
latter
three
clade
infect
rad
inde
prolong
mean
surviv
time
delay
weight
loss
decreas
lung
viral
yield
effect
rad
compar
enhanc
compar
previous
report
np
mspecif
amirna
conclus
data
prove
feasibl
rad
potenti
antivir
reagent
addit
studi
includ
combin
amirna
compound
requir
optim
prophylact
effici
cell
cultur
transfect
human
embryon
kidney
hek
human
embryon
kidney
hek
vero
mdck
cell
line
purchas
shanghai
cell
bank
chines
academi
scienc
maintain
dulbecco
modifi
eagl
medium
hyclon
beij
china
supplement
fetal
bovin
serum
gemini
biolog
product
calabasa
ca
uml
penicillin
streptomycin
hyclon
transfect
perform
xtreme
gene
hp
dna
transfect
reagent
roch
indianapoli
accord
manufactur
guidanc
brief
indic
dose
plasmid
mix
xtreme
reagent
ratio
optimem
gbico
grand
island
ny
transfect
complex
incub
room
temperatur
minut
transfer
directli
cell
plate
cultur
incub
hour
process
treatment
influenza
viru
strain
clade
clade
clade
clade
propag
inocul
allanto
caviti
specificpathogenfre
spf
chicken
embryo
incub
hour
allanto
fluid
collect
preserv
experi
involv
conduct
biosafeti
level
contain
facil
fudan
univers
shanghai
china
design
gener
artifici
microrna
hemagglutinin
target
artifici
mirna
design
invitrogen
blockit
pol
ii
mir
rnai
design
http
rnaidesign
invitrogencomrnaiexpress
four
bestsuit
singlestrand
oligonucleotid
synthes
anneal
doublestrand
oligo
clone
mirna
express
vector
pcdna
invitrogen
carlsbad
ca
premirna
sequenc
shown
tabl
negmirna
control
plasmid
provid
blockitpol
ii
mir
rnai
express
vector
kit
serv
neg
control
gener
recombin
adenovirus
recombin
adenovirus
construct
previous
brief
complet
artifici
amirna
express
cassett
vector
amplifi
pcr
ligat
pshuttl
vector
clonetech
mountain
view
ca
digest
iceui
piscei
fragment
subclon
region
chimpanzeeorigin
adenoviru
molecular
clone
construct
verifi
enzym
digest
sequenc
recombin
adenovirus
gener
transfect
paci
linear
plasmid
hek
cell
rescu
ad
expend
hek
cell
purifi
cesium
chlorid
densitygradi
centrifug
viru
concentr
measur
spectrophotometri
absorb
nm
radempti
construct
strategi
appli
mock
control
viru
follow
studi
micesix
eightweekold
femal
icr
mice
obtain
shanghai
laboratori
anim
center
china
hous
biosafeti
level
laboratori
fudan
univers
anim
studi
conduct
accord
guidelin
institut
anim
care
use
committe
institut
pasteur
shanghai
western
blot
analysi
prove
rad
reduc
hemagglutinin
express
western
blot
conduct
adenoviru
ad
treat
vero
cell
subsequ
infect
differ
clade
brief
vero
cell
plate
per
well
plate
previou
day
inocul
indic
dose
rad
radempti
pretreat
cell
serv
control
twentyfour
hour
later
cell
infect
individu
four
differ
clade
virus
dose
multipl
infect
moi
harvest
hour
protein
express
level
detect
rabbit
polyclon
antibodi
ha
sino
biolog
beij
china
follow
horseradish
peroxidaseconjug
secondari
antibodi
sigmaaldrich
st
loui
mo
express
sigmaaldrich
measur
normal
control
protein
load
signal
detect
use
chemiluminesc
detect
system
ge
health
life
scienc
pittsburgh
pa
plaqu
reduct
assay
inhibit
plaqu
format
perform
modifi
plaqu
assay
mdck
cell
seed
sixwel
plate
densiti
cell
per
well
hour
prior
ad
incub
confluent
monolay
treat
serial
dilut
rad
vp
vp
radempti
vp
cultur
hour
forti
plaqueform
unit
viru
dilut
serumfre
dulbecco
modifi
eagl
medium
bovin
serum
albumin
ad
well
absorb
hour
incub
supernat
remov
mdck
cell
wash
phosphatebuff
salin
pb
hyclon
overlaid
minimum
essenti
media
mem
gibco
contain
agar
bsa
plate
maintain
seventytwo
hour
later
cell
fix
formaldehyd
stain
crystal
violet
assay
repeat
triplic
vaccin
challeng
group
icr
mice
mice
per
group
intranas
treat
vp
rad
volum
day
prior
iv
challeng
equival
dose
radempti
inocul
mice
serv
neg
control
dilut
pb
given
mous
anesthesia
five
mice
group
sacrif
dpi
lung
tissu
taken
virolog
histolog
examin
weight
loss
surviv
rate
remain
mice
observ
daili
day
mice
excess
weight
loss
would
euthan
consid
anim
welfar
viral
load
titrat
influenza
viru
rna
copi
determin
quantit
realtim
pcr
previous
prove
good
agreement
tradit
titrat
method
higher
briefli
total
rna
treat
cell
isol
trizol
invitrogen
follow
manufactur
protocol
purifi
rna
dissolv
diethylpyrocarbonatetr
water
takara
dalian
china
concentr
qualiti
determin
nanodrop
spectrophotometr
thermo
scientif
wilmington
de
onehundr
nanogram
total
rna
retrotranscrib
use
mmlv
revers
transcriptas
kit
promega
san
lui
obispo
ca
univers
primer
uni
complementari
conserv
end
influenza
flu
gene
express
subsequ
assay
realtim
pcr
system
appli
biosystem
foster
citi
ca
follow
primer
matrix
forward
matrix
revers
forward
revers
amplif
achiev
reaction
contain
cdna
sybr
premix
ex
taq
tlirnaseh
plu
takara
forward
primer
revers
primer
rox
refer
reaction
start
denatur
second
follow
time
cycl
second
second
sampl
amplifi
triplic
rel
flu
gene
express
quantifi
compar
ct
method
normal
express
data
analyz
system
sd
version
appli
biosystem
foster
citi
ca
lung
tissu
harvest
mice
dpi
store
rna
isol
tissu
mechan
homogen
precelli
bertin
technolog
franc
icecold
pb
homogen
centrifug
rpm
minut
supernat
appli
viral
load
titrat
viral
copi
determin
absolut
quantif
gene
express
vector
use
provid
standard
curv
viral
copi
number
normal
mass
lung
histolog
lung
tissu
dissect
mice
dpi
fix
paraformaldehid
hour
hematoxylin
eosin
stain
perform
previous
patholog
section
evalu
doubl
blind
guarante
object
histolog
chang
score
follow
observ
patholog
perivascular
infiltr
perivascular
interstiti
infiltr
affect
lobe
section
perivascular
interstiti
infiltr
affect
lobe
section
perivascular
interstiti
infiltr
affect
lobe
section
statist
analys
spss
chicago
il
use
statist
analys
viral
yield
patholog
score
plaqu
count
compar
student
ttest
oneway
analysi
varianc
chisquar
test
appli
assess
differ
surviv
rate
p
consid
statist
signific
